The $1 billion acquisition of Vascular Solutions has been completed by Teleflex after receiving approval from Vascular Solutions' shareholders. The $56-per-share transaction expands Teleflex's vascular and interventional businesses with the addition of a portfolio of over 90 coronary and peripheral vascular devices.
Johnson & Johnson subsidiary Ethicon has agreed to pay an undisclosed amount for Minnesota-based Torax Medical, a maker of surgical devices for treating gastroesophageal reflux disease and bowel incontinence. The acquisition is expected to be completed by the end of next month.
A round of debt and options financing involving 37 unnamed sources has brought in $2.6 million for Pittsburgh-based ALung Technologies, according to a filing with the SEC. The company, which makes the Hemolung RAS extracorporeal carbon dioxide removal device for treating acute respiratory failure, did not disclose how it intends to use the proceeds and is still seeking to raise $1.4 million in the round.
Financing worth about $2.2 million has been secured by Irish medtech company OncoMark from various investors that include Kernel Capital and the Galway HBAN MedTech syndicate. The money will be used to commercialize the company's OncoMasTR test, which uses screening to lower the number of patients undergoing unnecessary chemotherapy for breast cancer, as well as to expand its workforce.
A report from Orbis Research predicts the US intraoperative neuromonitoring market will see a 9% compound annual growth rate through 2020 due to a higher demand for patient safety. Among the key market players are Medtronic, NuVasive, Biotronic NeuroNetwork, Computational Diagnostics and Natus Medical.
Data from a 24-patient feasibility study of Insulet's Omnipod Horizon hybrid closed-loop system showed positive results in patients with type 1 diabetes. At 36 hours, use of a modified version of the Omnipod, along with Insulet's personalized model predictive control algorithm and a Dexcom continuous glucose monitor, demonstrated safety, significantly improved overnight glucose control and lowered hypoglycemia during the day and night.
Japan's Pharmaceuticals and Medical Device Agency has given Medtronic approval for its Micra transcatheter pacing system, a leadless pacemaker intended to be implanted in the right ventricle using a catheter to provide single-chamber pacing. The device can be used for full-body MRI scans and has an estimated battery life of 12 years.
The FDA has given Hologic premarket approval for its Aptima HCV Quant Dx assay, which is intended for viral load measurement and confirmation of hepatitis C virus infection. The assay, which operates on the automated Panther system, quantifies sustained antiviral response throughout all major genotypes and uses real-time transcription-mediated amplification.
A recall initiated by Zimmer Biomet involving 3,662 units of its Comprehensive Reverse Shoulder System has been classified by the FDA as Class I. The recall was issued because the shoulder replacement devices demonstrate a higher rate of fractures, which may necessitate revision surgeries, compared with what is indicated on the label.
Feb. 21-22, 2017 | Bogota, Colombia Developed by industry and association leaders for the medical device industry and based on the latest and emerging trends in global medical technology compliance, the 2017 Latin America Compliance Conference is the most comprehensive medical technology meeting for device industry executives, specialty device industry lawyers, compliance professionals, international policymakers and other industry stakeholders focused on Latin American compliance issues. The conference will bring together device industry regulators, compliance professionals, legal counsel, senior executives and industry observers to analyze the major compliance challenges of the day and to discuss approaches to practical and effective management and compliance across the region. Learn more.
The AdvaMed Purchasing Group is a new member-only benefit that helps companies purchase the very best goods and services from nationally recognized suppliers at the very best cost, using a trusted and proven vetting system and the collective purchasing power of our membership. Participation is free for AdvaMed members, and there are no minimum commitments. Get started today.